HL-A antigen changes in patients treated with chloramphenicol.
D000328:Adult; D000686:Amyloidosis / Q000276:immunology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D001996:Bronchopneumonia / Q000276:immunology; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology* / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D003864:Depression, Chemical; D003967:Diarrhea / Q000276:immunology; D004314:Down Syndrome / Q000276:immunology; D004403:Dysentery / Q000276:immunology; D000939:Epitopes; D005873:Giardiasis / Q000276:immunology; D006649:Histocompatibility Antigens; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects*; D008457:Measles / Q000188:drug therapy / Q000276:immunology; D010641:Phenotype; D011014:Pneumonia / Q000276:immunology; D011817:Rabbits / Q000276:immunology
D000900:Anti-Bacterial Agents; D000939:Epitopes; D006649:Histocompatibility Antigens; D002701:Chloramphenicol